TNFSF10 and head and neck squamous cell carcinoma: Subsequently, we focused on characterizing TNF, LTA (LT-α), LTB (LT-β), FASLG (FasL) and TNFSF10 (TRAIL) expression by healthy donor- and HNSCC patient-associated circulating B cells (Figure 3A).